You searched for "floaters"

561 results found

Contemporary glaucoma therapy: spoilt for choice

The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Childhood glaucoma

When a child is given a diagnosis of glaucoma, the impact upon that child and their family is enormous; equivalent to the diagnosis of a cancer [14]. This previously published article (2019) outlines the knowledge, techniques and approaches that offer...

VISION 2020 LINKS Programme and DR-NET World Sight Day Workshop

World Sight Day (WSD) was celebrated globally on 8 October 2020 [1]. From Australia and the Pacific to the Americas, via Asia, Africa and the Caribbean, awareness-raising and advocacy activities took place throughout the day, to focus attention on unnecessary...

Part 2: Good news, bad news at the international conference

In the second instalment of this two-part article (click here for Part 1), our editor Peter Cackett presents the ‘good news’ and ‘bad news’ from an international conference experience. Readers will remember that in the last issue I left you...

Visual disturbance heralding stroke: are we seeing the signs in time?

Isolated visual symptoms may be an early presenting feature of stroke, and timely recognition of such atypical cases is important because treatment for stroke has a limited time-window of efficacy. Stroke occurs in approximately 150,000 people per year in the...

The fragile p-value

Abdus Samad Ansari explores the limitation of the p-value and the application of the fragility index in clinical trials. Clinical trials and tribulations? The restoration of vision or more purely the gift of sight is an aspect of care that...

My top five: Emerging alternatives to manage and treat nAMD

Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

NHS leaders must support doctors to act on new GMC guidance to challenge concerning behaviour at work

Dr John Holden responds to the publication of the revised Good Medical Practice (GMP) guidance from the General Medical Council.

Thomas Truckenbrod awarded for his outstanding contribution to the optical profession

The International Opticians Association (IOA) has given Thomas Truckenbrod a special award recognising his outstanding contribution to the optical profession. The award was presented by IOA director of development Elaine Grisdale at the SILMO d’Or ceremony on Saturday 30 September in Paris.

ABDO to be featured in ITN Business ‘Global Action for Eye Health’ programme

The Association of British Dispensing Opticians (ABDO) is pleased to announce that on World Sight Day (10 October), we will be featuring in an ITN Business news-style programme, ‘Global Action for Eye Health’, aiming to raise awareness and drive action towards improved eye health worldwide.

EQUALeyes: Illuminating insights into using health data, AI and inclusion

Reflecting the Bloomsbury Festival theme of Human.Kind, and current public conversations on the benefits and potential threats of AI, we bring together leaders in the field of healthcare AI to discuss key issues, with a special focus on eyes.